Potomac Capital Management »

Gain Therapeutics shares owned by Potomac Capital Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Potomac Capital Management from 13F filings

Historical chart of Potomac Capital Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Potomac Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Potomac Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3M 1.0M 3.22